June 25 (Reuters) - AbbVie said on Tuesday the U.S. Food and Drug Administration has rejected the company's marketing application for its therapy to treat motor fluctuations in adults with advanced Parkinson's disease. (Reporting by Sneha S K in Bengaluru; Editing by Vijay Kishore)
US FDA declines to approve AbbVie's Parkinson's disease therapy
![Reuters logo](/images/reuters.jpg)